SpaceX IPO: History Says the Stock Will Do This When It Starts Trading.

SpaceX is reportedly targeting a $1.75 trillion IPO valuation and could host its roadshow in early June, putting a summer listing on track. The article argues that large IPOs have historically underperformed, citing an average 13% decline over the first three months and 12% over the first year for the 10 largest U.S. IPOs. It also notes conflicting estimates for SpaceX’s 2025 financials, with reports ranging from an $8 billion profit on $16 billion of revenue to a $5 billion loss on $18 billion of revenue.

Analysis

The important implication is not “IPO pops then fades” — it is that a marquee listing at a premium to the most recent private mark tends to pull forward every optimistic assumption at once: growth durability, margin structure, and eventual monetization of adjacent ventures. That creates a fragile post-debut setup because any modest disappointment in disclosure quality or unit economics becomes a multiple compression event, not just a fundamentals issue. In that context, the more crowded trade may actually be the ecosystem beneficiaries that investors buy ahead of the listing, not the listing itself.

Second-order pressure lands on the private-markets complex. A successful roadshow at this scale can temporarily validate late-stage venture marks across deep-tech, aerospace, and AI infrastructure, but it also raises the bar for every comparable private asset that now has to clear a public-market hurdle rate. If the deal prints at the top of the range, expect a short-lived halo for high-beta growth names; if it prices below that, the repricing can bleed into other private crossover stories and weaken risk appetite for venture-backed secondaries.

The contrarian miss is that the first 1-3 months matter more than the first year. The stock can trade like a scarcity object in the initial weeks, especially if free float is constrained, while the real downside often comes after lockup and sell-side model resets. The cleanest expression is to avoid chasing the debut and instead look for a post-IPO unwind once operating disclosures, capital intensity, and incremental dilution become visible to the market.

Relative-value read-throughs are more nuanced: the article’s negative tone is supportive for later-stage unprofitable IPO comparables and mildly constructive for platform beneficiaries that can absorb speculative capital during the event window. But if this namesake listing becomes the new benchmark for “AI + deep tech + national champion” valuations, it could actually widen the dispersion between public winners with real cash generation and private names still asking for narrative premiums.

Key Decisions for Investors

• Do not chase the IPO at debut; prefer to wait 30-90 days post-listing for the first earnings-style disclosure window, when valuation support usually breaks if growth or margins miss the narrative.
• Use any IPO-induced risk-on bid to trim weak late-stage growth proxies and unprofitable IPO comps such as RIVN and CPNG; these names are most vulnerable if public markets tighten underwriting standards for high-multiple listings.
• Pair trade: long profitable mega-cap AI/platform exposure (META, NVDA) vs. short speculative pre-/post-IPO high-beta growth baskets; the former should attract the capital rotating out of the debut once hype fades.
• If the stock prices at a very rich multiple, consider put spreads 2-4 months post-listing rather than front-running the debut; implied vol will likely remain elevated, but the risk/reward improves once lockup overhang and analyst models hit.
• Watch UPS and T only as sentiment barometers rather than direct shorts; if the IPO appetite is strong enough to support a trillion-dollar listing, it can briefly lift broad market beta, but that effect should be used to fade strength in laggard defensive names rather than chase them.